White Paper
The Impact of Formulary Controls on Commercially Insured Patients in Five Chronic Therapeutic Areas
Jul 29, 2025

Formulary controls such as prior authorizations and step therapy are increasingly used by commercial payers, often delaying treatment and increasing prescription abandonment among patients. These restrictions disproportionately affect lower-income and medically complex patients, raising concerns about equitable access to care. While they may reduce short-term costs, the long-term impact includes higher medical expenses and poorer health outcomes, prompting calls for more transparent and patient-centered formulary strategies.

Related solutions

Contact Us